UnknownEarly Phase 1

Xylitol Chewable Tablets Versus Xylitol Chewing Gum in Geriatric Bedridden Patients

Egypt98 participantsStarted 2019-09-01

Plain-language summary

This study will be conducted to evaluate the effectiveness of using dissolving Xylitol chewable tablets versus xylitol chewing gum with bedridden geriatric patients in increasing salivary pH and decreasing bacterial count in both saliva and interdental plaque.

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age range above 65 years old
✓. Bedridden patients
✓. Males or females
✓. Concious patients
✓. Co-operative patients approving to participate in the trial.
✓. Subjects who signed informed consent

Exclusion criteria

✕. Individuals had taken antibiotics during the last four weeks or anticipated doing so during the study
✕. Subjects who wore removable prosthesis
✕. Patients with systemic diseases that have any oral manifestations
✕. History of Smoking
✕. Allergy to any of chewing gum or tablets ingredients
✕. Evidence of tempromandibular joint disorders
✕. Presence of intraoral infections
✕. Currently using any mouth rinse

What they're measuring

Salivary bacterial count

Timeframe: 15 days

Trial details

NCT IDNCT03877705

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-09-01

Contact for this trial

Manar MA Abd elmageed, Resident

+021287766120 dentalmena90@gmail.com

View on ClinicalTrials.gov More Saliva Altered trials